Patient characteristics of NLPHL and cHL.
| Patients . | NLPHL (n= 394) . | cHL (n= 7904) . |
|---|---|---|
| Data from the German Hodgkin Study Group. | ||
| Abbreviations: NLPHL, nodular lymphocyte-predominant Hodgkin lymphoma; cHL, classical Hodgkin lymphoma | ||
| Age, median (years) | 37 | 33 |
| Female (%) | 25 | 44 |
| Male (%) | 75 | 56 |
| B symptoms (%) | 9 | 40 |
| Early stage (%) | 63 | 22 |
| Intermediate stage (%) | 16 | 39 |
| Advanced stage (%) | 21 | 39 |
| Patients . | NLPHL (n= 394) . | cHL (n= 7904) . |
|---|---|---|
| Data from the German Hodgkin Study Group. | ||
| Abbreviations: NLPHL, nodular lymphocyte-predominant Hodgkin lymphoma; cHL, classical Hodgkin lymphoma | ||
| Age, median (years) | 37 | 33 |
| Female (%) | 25 | 44 |
| Male (%) | 75 | 56 |
| B symptoms (%) | 9 | 40 |
| Early stage (%) | 63 | 22 |
| Intermediate stage (%) | 16 | 39 |
| Advanced stage (%) | 21 | 39 |